Adocia’s Intellectual property
Adocia’s Intellectual property comprises around 47 patent families covering the scope of its research activities.
These families are made up of approximately 96 patent applications and 67 granted patents.
More precisely, Adocia’s portfolio consists mainly of patents and patent applications within the following fields:
- Chronic Wound Healing, with 26 patents already granted
- Insulin Therapy (diabetes), with 34 patents already granted
- Monoclonal Antibodies (mAb), a new domain with 3 patents granted
In general, the filing strategy usually entails a first patent application to be filed in France, with a provisional US patent to be filed during pre-AIA (America Invents Act) time, and a PCT extension as well as, in certain cases, the filing of a regular patent application in the US.